Four Good Finance Articles To Read Today

Check out this article by Dividend Mantra:

It’s titled “Why I Hold 100% Of My Investments In A Taxable Account.” This, my friends, is how you think through a decision. Jason explains what the conventional wisdom is with retirement asset allocation, and then goes on to explain why it makes sense for his own financial planning to deviate from that. That is exactly how you should approach problems in life—you figure out what the generally accepted “good” practice is for a given situation, and then you apply the facts of your own life to see if it fits. Jason’s Dividend Mantra blog is one of the best homages to good judgment and critical thinking that is out there today.

Continue Reading!

Originally posted 2013-08-21 23:38:08.

What Are Quality Dividend Stocks, And Why Should You Own Them?

If you are familiar with some of my writings, you have probably encountered my use of the phrase “high-quality dividend stock” to describe the kind of company worth buying and tucking away in your portfolio for decades to come.

Even though I like the phrase a lot, it is one of those descriptive terms that has fallen victim to overkill and probably cause eyes to glaze over when the word is used on a repetitive basis. That’s why I wanted to scribble down a quick post to state the obvious—what exactly I mean when I talk about high-quality assets, and why I think they make great investments for you on your life’s financial journey.

Continue Reading!

Originally posted 2013-08-20 23:53:13.

Davita Stock’s March to $100

Although it does not receive much coverage, healthcare company Davita has quietly become one of Berkshire Hathaway’s fifteen largest holdings. Davita is a $12 billion company, and Berkshire owns 19.2% of the stock, which carries a present value of $2.3 billion. Since becoming publicly traded in 1995, Davita has compounded at a rate of 13.2% annualized, turning every dollar invested in the stock into just shy of $17 over this time frame.

What I like about the business is the simplicity and necessity of its business model. It provides dialysis services and aids in other treatments for kidney failure at an average rate of $350 per treatment, approximately 7% or $24.50 of which flows through to shareholders as net profits after all expenses including taxes are paid.

Continue Reading!

Clorox Stock’s Wildly Low Cash Position

Given the amount of lay investors, pension funds, insurance/institutional funds, endowments, and charity-related funds that are invested into the stocks that we regard as the blue-chip members of the S&P 500, it would make sense that these companies be conservatively financed so that there is always cash on fund to fund an emergency. Coca-Cola has $19 billion in available. Johnson & Johnson has $19 billion in cash. Procter & Gamble has $11 billion in cash. This is what you would expect from the backbones of American business.

Continue Reading!